Castleark Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
Castleark Management's VCYT Position: Q2 2026 in Review
Castleark Management opened a new position in Veracyte (VCYT) in Q2 2026: 72,016 shares worth $4.23M. The stake represents 0.11% of the portfolio and ranks #173 among its holdings. This is a return to the name: Castleark Management previously reported a position in VCYT as recently as Q1 2025.
Castleark Management first reported a position in VCYT in Q1 2019 and has held it in 15 quarters since. The position peaked at $12.3M in Q4 2020. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Castleark Management held 72,016 shares of Veracyte worth $4.23M as of Q2 2026.
- Veracyte was a new Castleark Management position in Q2 2026.
- Veracyte made up 0.11% of Castleark Management's portfolio in Q2 2026, its #173 holding.
- Castleark Management first reported a position in Veracyte in Q1 2019 and has held it in 15 quarters since.
- Castleark Management's Veracyte position peaked at $12.3M in Q4 2020.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Castleark Management's 13F filing for Q2 2026, filed 14 Aug 2026.